Skip to main content

REVIEW article

Oncol.Rev.
Sec. Oncology Reviews: Reviews
Volume 18 - 2024 | doi: 10.3389/or.2024.1430237

Post Translational Modification of PTEN Protein: Quantity and Activity

Provisionally accepted
Xiao Li Xiao Li 1Pu Yang Pu Yang 1Xiaoli Hou Xiaoli Hou 1Shaoping Ji Shaoping Ji 2*
  • 1 Zhengzhou Shuqing Medical College, Zhengzhou, Henan Province, China
  • 2 Henan University, Kaifeng, China

The final, formatted version of the article will be published soon.

    Post-translational modifications play a crucial role in regulating protein function and stability. PTEN is a crucial tumor suppressor involved in regulating cellular proliferation, survival and migration processes. However, dysregulation of PTEN is common in various human cancers. Its stability and activation/suppression have been extensively studied in the context of tumorigenesis through inhibiting PI3K/AKT signaling pathway. PTEN undergoes diverse post-translational modifications, primarily including phosphorylation, acetylation, ubiquitination, SUMOylation, neddylation and oxidation, which finely tune PTEN activity and stability. Generally, phosphorylation can modulate PTEN's activity by affecting its lipid phosphatase function, leading to an altered power of the signaling pathways. Acetylation influences PTEN protein stability and degradation rates. SUMOylation has been implicated in PTEN localization and interaction with other proteins, affecting its overall function. In addition, neddylation, as a novel modification of PTEN, is also a key regulatory mechanism for the loss of tumor suppressor function of PTEN. Although current therapeutic approaches focus primarily on inhibiting PI3 kinase, understanding the post-translational modification of PTEN could help provide new therapeutic strategies that restore PTEN's role in PIP3-dependent tumors. In this review, we will summarize the major recent progress in regulation of PTEN protein level and activity. Finally, we hope that these insights will contribute to a better understanding of this critical tumor suppressor and its potential implications for cancer therapy in future.

    Keywords: Pten, Phosphorylation, Acetylation, Ubiquitination, Sumoylation

    Received: 09 May 2024; Accepted: 04 Jul 2024.

    Copyright: © 2024 Li, Yang, Hou and Ji. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Shaoping Ji, Henan University, Kaifeng, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.